1.15
price down icon2.54%   -0.03
after-market アフターアワーズ: 1.16 0.01 +0.87%
loading

Quince Therapeutics Inc (QNCX) 最新ニュース

pulisher
May 16, 2026

QNCX Should I Buy - Intellectia AI

May 16, 2026
pulisher
May 15, 2026

Nantahala Capital (QNCX) reports 4.53M shares, 7.52% stake disclosed - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Quince Therapeutics (QNCX) price target increased by 100.00% to 81.60 - MSN

May 15, 2026
pulisher
May 14, 2026

Quince Therapeutics stock (US74833Q1004): Analysts see 345% upside potential - AD HOC NEWS

May 14, 2026
pulisher
May 14, 2026

Quince Therapeutics (QNCX) price target increased by 900.00% to 40.80 - MSN

May 14, 2026
pulisher
May 14, 2026

QNCX Stock Chart | QUINCE THERAPEUTICS INC (NASDAQ:QNCX) - ChartMill

May 14, 2026
pulisher
May 12, 2026

TradingKey - TradingKey

May 12, 2026
pulisher
May 12, 2026

Why is QNCX stock up 60% pre-market after a near-total wipeout? - MSN

May 12, 2026
pulisher
May 11, 2026

QUE THERAPEUTICS ($QNCX) Releases Q1 2026 Earnings - Moomoo

May 11, 2026
pulisher
May 11, 2026

Quince Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 11, 2026
pulisher
May 11, 2026

Trial setback and cash strain shape Quince (NASDAQ: QNCX) Q1 update - Stock Titan

May 11, 2026
pulisher
May 08, 2026

Quince Therapeutics Inc expected to post a loss of $2.56 a shareEarnings Preview - TradingView

May 08, 2026
pulisher
May 08, 2026

MSN Money - MSN

May 08, 2026
pulisher
Apr 29, 2026

Quince Therapeutics Regains Nasdaq Bid Compliance Amid Valuation Risk - The Globe and Mail

Apr 29, 2026
pulisher
Apr 28, 2026

Quince Therapeutics (QNCX) restores bid compliance but still below $50M MVLS - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

Quince regains Nasdaq bid-price compliance but MVLS deficiency remains - TradingView

Apr 28, 2026
pulisher
Apr 27, 2026

Large reverse split, director election on deck at Quince Therapeutics (QNCX) meeting - Stock Titan

Apr 27, 2026
pulisher
Apr 27, 2026

SEC Form DEFA14A filed by Quince Therapeutics Inc. - Quantisnow

Apr 27, 2026
pulisher
Apr 27, 2026

Quince Therapeutics settles $16.4M debt with $5.5M payment - MSN

Apr 27, 2026
pulisher
Apr 26, 2026

Quince Therapeutics (QNCX) price target decreased by 21.74% to 6.12 - MSN

Apr 26, 2026
pulisher
Apr 24, 2026

Why did QNCX stock plummet over 90% today? - MSN

Apr 24, 2026
pulisher
Apr 23, 2026

Quince Therapeutics Appoints June Bray to Board - The Globe and Mail

Apr 23, 2026
pulisher
Apr 22, 2026

Quince Therapeutics appoints June Bray to board of directors By Investing.com - Investing.com Canada

Apr 22, 2026
pulisher
Apr 22, 2026

Quince Therapeutics appoints June Bray to board of directors - Investing.com

Apr 22, 2026
pulisher
Apr 22, 2026

[8-K] Quince Therapeutics, Inc. Reports Material Event - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

Quince Therapeutics, Inc. Appoints June Bray as Class I Director and to Nominating & Governance Committee, Audit Committee, and Compensation Committee, Effective April 22, 2026 - marketscreener.com

Apr 22, 2026
pulisher
Apr 21, 2026

QNCX Stock Price, Quote & Chart | QUINCE THERAPEUTICS INC (NASDAQ:QNCX) - ChartMill

Apr 21, 2026
pulisher
Apr 20, 2026

Quince Therapeutics (QNCX) Stock: Worth Entering? (-6.93%) 2026-04-20Top Breakouts - Xã Vĩnh Công

Apr 20, 2026
pulisher
Apr 18, 2026

QNCX Sees Increased Price Target Amidst Maintained Buy Rating | - GuruFocus

Apr 18, 2026
pulisher
Apr 18, 2026

Quince Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo

Apr 18, 2026
pulisher
Apr 18, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 18, 2026
$29.29
price down icon 0.71%
$89.55
price down icon 2.65%
$52.85
price down icon 1.03%
$109.14
price down icon 5.60%
ONC ONC
$293.27
price down icon 3.73%
$145.66
price down icon 2.55%
大文字化:     |  ボリューム (24 時間):